Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$113M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$109M |
| 3 |
Philip Morris
PM
|
+$60.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$58.6M |
| 5 |
eBay
EBAY
|
+$58.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$78.9M |
| 2 |
TSMC
TSM
|
+$58.1M |
| 3 |
PayPal
PYPL
|
+$40.8M |
| 4 |
Iron Mountain
IRM
|
+$33.2M |
| 5 |
Tractor Supply
TSCO
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.14% |
| 2 | Healthcare | 13.9% |
| 3 | Consumer Discretionary | 12.2% |
| 4 | Communication Services | 11.65% |
| 5 | Financials | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MON
276
DELISTED
Monsanto Co
MON
| $9.67M | 0.07% |
94,610
-15,265
| -14% | -$1.6M |
|
277
T. Rowe Price
TROW
$25B
| $9.54M | 0.07% |
143,380
-10,104
| -7% | -$704K |
|
278
Urban Edge Properties
UE
$2.94B
| $9.52M | 0.07% |
338,402
-72,992
| -18% | -$2.11M |
|
279
RTX Corp
RTX
$287B
| $9.47M | 0.07% |
148,173
| – | – |
|
|
HES
280
DELISTED
Hess
HES
| $9.38M | 0.07% |
174,932
+56,765
| +48% | +$3.04M |
|
281
Pentair
PNR
$10.2B
| $9.37M | 0.07% |
217,077
+32,069
| +17% | +$1.35M |
|
282
Eli Lilly
LLY
$1.07T
| $9.36M | 0.07% |
116,702
+20,913
| +22% | +$1.67M |
|
283
Boeing
BA
$165B
| $8.95M | 0.07% |
67,929
-6,347
| -9% | -$836K |
|
284
US Bancorp
USB
$99.6B
| $8.83M | 0.07% |
205,796
| – | – |
|
285
Biogen
BIIB
$29.9B
| $8.79M | 0.06% |
28,074
-1,911
| -6% | -$566K |
|
286
Goldman Sachs
GS
$313B
| $8.69M | 0.06% |
53,896
+4,004
| +8% | +$651K |
|
287
Sabra Healthcare REIT
SBRA
$5.64B
| $8.69M | 0.06% |
345,355
-29,839
| -8% | -$715K |
|
|
STAY
288
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $8.52M | 0.06% |
+600,000
| New | +$8.72M |
|
|
CONE
289
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.32M | 0.06% |
174,980
+6,686
| +4% | +$346K |
|
290
Thermo Fisher Scientific
TMO
$211B
| $8.2M | 0.06% |
51,546
-1,768
| -3% | -$272K |
|
291
W.W. Grainger
GWW
$65.3B
| $8.16M | 0.06% |
36,267
-25,794
| -42% | -$5.8M |
|
292
Texas Instruments
TXN
$255B
| $8.11M | 0.06% |
115,528
-6,495
| -5% | -$443K |
|
|
WPX
293
DELISTED
WPX Energy, Inc.
WPX
| $8.1M | 0.06% |
614,315
+197,667
| +47% | +$2.2M |
|
|
ALXN
294
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.01M | 0.06% |
65,395
-3,501
| -5% | -$451K |
|
295
Mondelez International
MDLZ
$77.7B
| $8.01M | 0.06% |
182,479
-8,029
| -4% | -$352K |
|
296
Occidental Petroleum
OXY
$57B
| $7.89M | 0.06% |
108,205
-79,948
| -42% | -$5.99M |
|
297
Bristol-Myers Squibb
BMY
$127B
| $7.81M | 0.06% |
144,812
-55,431
| -28% | -$3.56M |
|
298
American International
AIG
$41.9B
| $7.67M | 0.06% |
129,290
-9,007
| -7% | -$515K |
|
|
VASC
299
DELISTED
Vascular Solutions Inc
VASC
| $7.44M | 0.05% |
154,323
+95,824
| +164% | +$4.46M |
|
300
Crown Holdings
CCK
$12.8B
| $7.39M | 0.05% |
129,481
-1,843
| -1% | -$98.8K |
|
Similar funds
Janus Henderson Group's Q3 2016 Portfolio in Review
As of Q3 2016, Janus Henderson Group held 867 positions worth $13.6B, up 13% from $12B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group deployed $884M of net new capital in Q3 2016, opening 35 new positions and adding to 168 existing holdings. Its largest new stake was China Biologic Products Holdings, Inc.: 159,568 shares worth $19.9M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NetEase, an estimated $78.9M trimmed.
- Janus Henderson Group's largest Q3 2016 buy was China Biologic Products Holdings, Inc.: 159,568 shares worth $19.9M.
- Janus Henderson Group added most to Apple in Q3 2016, an estimated $113M increase.
- Janus Henderson Group's biggest Q3 2016 reduction was NetEase, cutting an estimated $78.9M.
- Janus Henderson Group fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $16.1M.
- Janus Henderson Group's ten largest holdings make up 23% of its $13.6B portfolio in Q3 2016.
- Janus Henderson Group opened 35 new positions and closed 49 in Q3 2016.
- Janus Henderson Group's portfolio value rose 13% quarter-over-quarter to $13.6B.
Based on Janus Henderson Group's 13F filing for Q3 2016, filed 24 Oct 2016.